Islet Cell (IA-2) Autoantibodies
Islet cell autoantibodies, or IA-2 antibodies, are produced as an autoimmune reaction against the islet cells of the pancreas. IA-2 is a tyrosine-like protein present in the dense granules of the pancreatic cells. IA-2 antibodies, in conjunction with other pancreas autoantibodies such as glutamic acid decarboxylase (anti-GAD) and anti-insulin, are present in 95% of patients with type 1 diabetes mellitus or insulin dependent diabetes mellitus (IDDM). Autoimmune destruction of insulin-producing pancreatic cells by these autoantibodies is known to be the primary cause of IDDM. The antibodies are produced early in the disease process when symptoms are not present. Once 80-90% of the pancreas cells are destroyed, diabetic symptoms begin to occur. Because these antibodies are present before clinical onset of disease, presence of them in asymptomatic individuals can be an early marker of IDDM.
These autoantibodies tend to be present more often in younger individuals and can be detected in patients as young as 3 years old. They also can appear later in the disease process which is known as "latent autoimmune diabetes in adulthood.” These patients are often mistakenly diagnosed with type 2 diabetes before the presence of the antibodies. The presence of more than one autoantibody type is proportional to the severity of disease progression; therefore, measurement of IA-2 in conjunction with anti-GAD and anti-insulin antibodies can aid the physician in diagnosis, treatment, and management of patients with type 1 diabetes.
- Aid in early detection of type 1 diabetes (IDDM)
- Aid in treatment and management of type 1 diabetes (IDDM)
- Distinguishes type 1 diabetes from type 2 diabetes
Presence of IA-2 autoantibody is supportive of:
- A diagnosis of type 1 diabetes
- A high risk for development of type 1 diabetes
- A need for insulin therapy
0.0-0.8 U/mL
Serum (Red or SST).
Stability
- Ambient: 48 hours
- Refrigerated: 7 days
- Frozen: 24 months
- Clin Chem. 1997; 43(12):2358-63. [PMID: 9439455]
- Clin Lab Med. 1997 Sep;17(3):499-545. [PMID: 9316771]
- Diabetes Care. 1997; 20(2):208-14 (review). [PMID: 9118776]
- Burtis C, Ashwood E and Bruns D. Fundamentals of Clinical Chemistry. St. Louis: Saunders (2008).